A Case of Early Stage Bladder Carcinosarcoma in Late Recurrence of Urothelial Carcinoma after Transurethral Resection.

Daisaku Hirano, Toshiyuki Yoshida, Daigo Funakoshi, Fuminori Sakurai, Shou Ohno, Yoshiaki Kusumi
Author Information
  1. Daisaku Hirano: Department of Urology, Higashimatsuyama Municipal Hospital, Higashimatsuyama 355-0041, Japan. ORCID
  2. Toshiyuki Yoshida: Department of Urology, Higashimatsuyama Municipal Hospital, Higashimatsuyama 355-0041, Japan.
  3. Daigo Funakoshi: Department of Urology, Nihon University School of Medicine, Tokyo 173-8610, Japan.
  4. Fuminori Sakurai: Department of Urology, Nihon University School of Medicine, Tokyo 173-8610, Japan.
  5. Shou Ohno: Department of Urology, Kawaguchi Municipal Medical Center, Kawaguchi 333-0833, Japan.
  6. Yoshiaki Kusumi: Department of Pathology, Nihon University School of Medicine, Tokyo 173-8610, Japan.

Abstract

Carcinosarcomas of the urinary bladder are rare biphasic neoplasms, consisting of both malignant epithelial and malignant mesenchymal components, and the prognosis of this tumor is unfavorable in most patients with even possibility of resection of disease. A 77-year-old male with a history of transurethral resection (TUR) of urothelial carcinoma (UC) of the bladder and adjuvant intravesical chemotherapy with pirarubicin 10 years ago revisited our department with a gross hematuria. Cystoscopy demonstrated an approximately 2.5���cm nonpapillary tumor on the right wall of the bladder. Pelvic MRI showed the tumor without extending the base of the bladder wall. The tumor could be completely removed with TUR. The malignant epithelial elements consisted of high-grade UC and the majority of mesenchymal components were fibrosarcomatous differentiation based on immunohistochemical studies. The tumor could be pathologically also suspected to be an early stage on TUR specimens. Although he has received no additional intervention due to the occurrence of myocardial infarction at three weeks after the TUR, he has been alive with no evidence of recurrence of the disease 27 months after the TUR. Some early stages of bladder carcinosarcoma might have a favorable prognosis without aggressive treatments.

References

  1. Scand J Urol Nephrol Suppl. 2008 Sep;(218):95-109 [PMID: 18815924]
  2. Semin Diagn Pathol. 1993 May;10(2):118-27 [PMID: 8367621]
  3. J Urol. 2007 Dec;178(6):2302-6; discussion 2307 [PMID: 17936803]
  4. Am J Surg Pathol. 1994 Mar;18(3):241-9 [PMID: 7509574]
  5. Mod Pathol. 2009 Jan;22(1):113-8 [PMID: 18997737]
  6. Korean J Urol. 2010 Oct;51(10):724-8 [PMID: 21031095]
  7. J Urol. 1998 May;159(5):1497-503 [PMID: 9554341]
  8. Asian Pac J Cancer Prev. 2012;13(11):5729-33 [PMID: 23317247]
  9. Case Rep Med. 2011;2011:349518 [PMID: 21629803]
  10. Hum Pathol. 2000 Mar;31(3):332-40 [PMID: 10746676]
  11. Virchows Arch. 2008 Apr;452(4):457-63 [PMID: 18266004]
  12. Can Urol Assoc J. 2011 Aug;5(4):E69-73 [PMID: 21806898]
  13. Sarcoma. 2010;2010: [PMID: 20706685]
  14. Clin Genitourin Cancer. 2016 Oct;14(5):366-372 [PMID: 27050715]
  15. Eur Urol. 2000 Mar;37(3):350-7 [PMID: 10720865]
  16. Hum Pathol. 1991 Mar;22(3):207-9 [PMID: 1848525]

Word Cloud

Created with Highcharts 10.0.0bladdertumorTURmalignantepithelialmesenchymalcomponentsprognosisresectiondiseaseUCwallwithoutearlyCarcinosarcomasurinaryrarebiphasicneoplasmsconsistingunfavorablepatientsevenpossibility77-year-oldmalehistorytransurethralurothelialcarcinomaadjuvantintravesicalchemotherapypirarubicin10yearsagorevisiteddepartmentgrosshematuriaCystoscopydemonstratedapproximately25���cmnonpapillaryrightPelvicMRIshowedextendingbasecompletelyremovedelementsconsistedhigh-grademajorityfibrosarcomatousdifferentiationbasedimmunohistochemicalstudiespathologicallyalsosuspectedstagespecimensAlthoughreceivedadditionalinterventiondueoccurrencemyocardialinfarctionthreeweeksaliveevidencerecurrence27monthsstagescarcinosarcomamightfavorableaggressivetreatmentsCaseEarlyStageBladderCarcinosarcomaLateRecurrenceUrothelialCarcinomaTransurethralResection

Similar Articles

Cited By